Fortress Biotech Inc. (FBIO)
1.62
-0.11 (-6.36%)
At close: Mar 28, 2025, 3:59 PM
Fortress Biotech Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 80.93M | 178.27M | 305.74M | 233.35M | 136.86M | 65.51M | 113.92M | 88.29M | 98.18M | 49.76M | 99.52M | 40.2M | 23.16M |
| Short-Term Investments | n/a | n/a | n/a | n/a | 15M | 17.6M | 39.03M | 3.39M | n/a | 20M | n/a | n/a | n/a |
| Long-Term Investments | n/a | 2.69M | 2.22M | 17.57M | 11.15M | 16.07M | 1.39M | 1.41M | 2.48M | 4.16M | n/a | n/a | n/a |
| Other Long-Term Assets | 6.72M | 3.66M | 3.42M | 2.66M | 17.73M | 16.35M | 18M | 16.25M | 14.79M | 14.66M | 104K | 349K | n/a |
| Receivables | 15.39M | 28.35M | 23.79M | 19.35M | 14.4M | 7.59M | 8.38M | 8.69M | n/a | n/a | n/a | n/a | n/a |
| Inventory | 10.21M | 14.16M | 9.86M | 1.4M | 857K | 678K | 171K | 203K | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 10.5M | 9.66M | 7.07M | 12.05M | 4.13M | 19.82M | 44.3M | 9.06M | 3.2M | 1.4M | 1.02M | 786K | 430K |
| Total Current Assets | 117.02M | 230.43M | 346.46M | 261.57M | 156.25M | 111.21M | 183.18M | 109.63M | 99.78M | 70.46M | 100.03M | 40.59M | 23.38M |
| Property-Plant & Equipment | 23.5M | 33.01M | 34.07M | 32.41M | 33.91M | 12.02M | 9.51M | 7.38M | 309K | 52K | 447K | 51K | n/a |
| Goodwill & Intangibles | 20.29M | 27.2M | 12.55M | 14.63M | 7.38M | 1.42M | 33.87M | 36.05M | 1.25M | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 50.5M | 63.87M | 50.04M | 67.26M | 70.17M | 29.79M | 62.77M | 61.1M | 18.83M | 18.87M | 551K | 400K | n/a |
| Total Assets | 167.53M | 294.3M | 396.5M | 328.83M | 226.42M | 140.99M | 245.95M | 170.73M | 118.61M | 89.33M | 100.58M | 40.99M | 23.38M |
| Account Payables | 34.81M | 57.24M | 47.43M | 11.41M | 35.45M | 17.86M | 10M | 14.21M | 1.87M | 366K | 468K | 1.03M | 575K |
| Deferred Revenue | n/a | 728K | 2.61M | n/a | 1.13M | 1.33M | 11.84M | 13.1M | 8.45M | n/a | 190K | n/a | n/a |
| Short-Term Debt | 9.45M | 12.63M | 7.43M | 6.37M | 10.79M | 19.08M | 13.23M | 2.03M | n/a | 165K | 6.2M | 1.8M | n/a |
| Other Current Liabilities | 39.8M | 56.39M | 43.23M | 33.84M | -623K | 18.68M | 48.21M | 40.32M | 8.71M | 3.55M | 4.35M | 2.3M | 2.92M |
| Total Current Liabilities | 84.91M | 127.72M | 101.04M | 47.96M | 45.62M | 55.61M | 67.43M | 56.56M | 10.58M | 4.08M | 11.21M | 5.13M | 3.49M |
| Long-Term Debt | 79.14M | 114.71M | 67.55M | 82.7M | 106.14M | 60.42M | 49.27M | 26.18M | 23.17M | 14.28M | 7.42M | 12.78M | 750K |
| Other Long-Term Liabilities | 1.89M | 1.85M | 2.03M | 1.95M | 2.14M | 5.21M | 4.74M | 5.01M | 584K | 454K | 679K | 1.04M | n/a |
| Total Long-Term Liabilities | 81.03M | 116.56M | 69.58M | 83.88M | 108.27M | 65.64M | 58.02M | 31.2M | 23.76M | 14.73M | 8.09M | 13.83M | 750K |
| Total Liabilities | 165.94M | 244.28M | 170.63M | 131.84M | 153.89M | 121.25M | 125.45M | 87.76M | 34.34M | 18.81M | 19.3M | 18.96M | 4.24M |
| Total Debt | 88.59M | 127.34M | 74.98M | 89.08M | 115.14M | 79.5M | 66.51M | 28.21M | 23.17M | 14.01M | 13.62M | 12.39M | 750K |
| Common Stock | 15K | 110K | 101K | 95K | 574K | 717K | 551K | 49K | 47K | 46K | 40K | 24K | 19K |
| Retained Earnings | -694.87M | -634.23M | -547.46M | -482.76M | -436.23M | -396.27M | -312.13M | -245.25M | -190.16M | -141.73M | -121.34M | -84.18M | -56.57M |
| Comprehensive Income | n/a | n/a | n/a | n/a | 500K | -2.56M | -1.65M | -481K | -68K | -42K | -20K | -3K | -23.38M |
| Shareholders Equity | 22.54M | 41.72M | 108.67M | 100.34M | 26.21M | 1.85M | 52.57M | 38.49M | 56.85M | 70.52M | 81.28M | 22.03M | 19.13M |
| Total Investments | 2.44M | 2.69M | 2.22M | 17.57M | 11.15M | 17.6M | 40.42M | 4.8M | 2.48M | 24.16M | n/a | n/a | n/a |